Browse > Article
http://dx.doi.org/10.4333/KPS.2011.41.4.205

Liposome/Tat Complex for Facilitating Genistein Uptake into B16 Melanoma Cells  

Park, Young-Mi (Division of Pharmaceutical Science, College of Pharmacy, Chung-Ang University)
Kang, Myung-Joo (Division of Pharmaceutical Science, College of Pharmacy, Chung-Ang University)
Moon, Ki-Young (Division of Pharmaceutical Science, College of Pharmacy, Chung-Ang University)
Park, Sang-Han (Division of Pharmaceutical Science, College of Pharmacy, Chung-Ang University)
Kang, Mean-Hyung (Division of Pharmaceutical Science, College of Pharmacy, Chung-Ang University)
Choi, Young-Wook (Division of Pharmaceutical Science, College of Pharmacy, Chung-Ang University)
Publication Information
Journal of Pharmaceutical Investigation / v.41, no.4, 2011 , pp. 205-210 More about this Journal
Abstract
Genistein (GT), a major isoflavone found in soybeans, has a potent antioxidant effect that protects the skin from UV-induced damages and malignant melanoma. In order to enhance the cellular uptake of GT, liposome/Tat complexes were prepared by an electrostatic interaction of anionic liposome (DMPC/DCP, 9:1 in molar ratio) with Tat peptide (0.02 to 0.08 mole), one of the well-known cell penetrating peptide (CPP). As the amount of Tat increased, the size increased but the zeta potential decreased. In vitro release study with dialysis membrane elicited GT release from liposomal preparations in a controlled manner. The addition of Tat increased GT release, especially for the initial period. In the cellular uptake study by incubating B16 melanoma cells with various liposomal preparations containing GT, B16 melanoma cells demonstrated a time-dependent increase of drug accumulation. Compared to the aqueous GT suspension, intracellular uptake was substantially enhanced by anionic liposomal formulation and further increased by the complex formulation. Therefore, liposome/ Tat complex might be a good candidate for facilitating intracellular drug delivery.
Keywords
Genistein; Liposome/Tat complex; B16 melanoma cell; Drug release; Cellular uptake;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Zhou, J.R., Mukherjee, P., Gugger, E.T., Tanaka, T., Blackburn, G.L., Clinton, S.K., 1998. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. Cancer Res. 58, 5231-5238.
2 Sander, C.S., Chang, H., Hamm, F., Elsner, P., Thiele, J.J., 2004. Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis. Int. J. Dermatol. 43, 326-335.   DOI
3 Spinozzi, F., Pagliacci, M.C., Migliorati, G., Moraca, R., Grignani, F., Riccardi, C., Nicoletti, I., 1994. The Natural Tyrosine Kinase Inhibitor Genistein Produces Cell-Cycle Arrest and Apoptosis in Jurkat T-Leukemia Cells. Leuk. Res. 18, 431-439.   DOI
4 Surh, Y.J., Chun, K.S., Cha, H.H., Han, S.S., Keum, Y.S., Park, K.K., Lee, S.S., 2001. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 480, 243-268.   DOI   ScienceOn
5 Temsamani, J., Vidal, P., 2004. The use of cell-penetrating peptides for drug delivery. Drug Discovery Today 9, 1012-1019.   DOI   ScienceOn
6 Torchilin, V.P., Rammohan, R., Weissig, V., Levchenko, T.S., 2001. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. U. S. A. 98, 8786-8791.   DOI
7 Vedavanam, K., Srijayanta, S., O'Reilly, J., Raman A., Wiseman, H., 1999. Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother. Res. 13, 601-608.   DOI
8 Wang, Y., Cao, J., Weng J.H., Zeng, S., 2005. Simultaneous determination of quercetin, kaempferol and isorhamnetin accumulated human beast cancer cells by high-performance liquid chromatography. J. Pharm. Biomed. Anal. 39, 328-333.   DOI
9 Wei, H., Saladi, R., Lu, Y., Wang, Y., Palep, S.R., Moore, J., Phelps, R., Shyong, E., Lebwohl, M.G., 2003. Isoflavone genistein: Photoprotection and clinical implications in dermatology. J. Nutr. 133, 3811S-3819S.
10 Booth, C., Hargreaves, D.F., Hadfield, J.A., McGown, A.T., Potten, C.S., 1999. Isoflavones inhibit intestinal epithelial cell proliferation and induce apoptosis in vitro. Br. J. Cancer 80, 1550-1557.   DOI
11 Hyndman, L., Lemoine, J.L., Huang, L., Porteous, D.J., Boyd, A.C., Nan, X., 2004. HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes. J. Control. Rel. 99, 435-444.   DOI
12 Lee, K.W., Lee, H.J., 2006. The roles of polyphenols in cancer chemoprevention. Biofactors 26, 105-121.   DOI
13 Ichihashi, M., Ahmed, N.U., Budiyanto, A., Wu, A., Bito, T.,Ueda, M., Osawa, T., 2000. Preventive effect of antioxidant on ultraviolet-induced skin cancer in mice. J. Dermatol. Sci. 23, S45-S50.   DOI
14 Kang, M.J., Eum, J.Y., Jeong, M.S., Choi, S.E., Park, S.H., Cho, H.I., Cho, C.S., Seo, S.J., Lee, M.W., Choi, Y.W., 2010. Facilitated skin permeation of oregonin by elastic liposomal formulations and suppression of atopic dermatitis in NC/Nga mice. Biol. Pharm. Bull. 33, 100-106.   DOI
15 Kwon, S.H., Kang M.J., Huh J.S., Ha, K.W., L, J.R., Lee, S.K., Lee, B.S., Han, I.H., Lee, M.S., Lee, M.W., Lee, J., Choi, Y.W., 2007. Comparison of oral bioavailability of genistein and genistin in rats. Int. J. Pharm. 337, 148-154.   DOI
16 Marty, C., Meylan, C., Schott, H., Ballmer-Hofer, K., Schwendener, R.A., 2004. Enhanced heparan sulfate proteoglycanmediated uptake of cell-penetrating peptide-modified liposomes. Cell. Mol. Life Sci. 61, 1785-1794.
17 Motlekar N., Khan, M.A., Youan, B-B.C., 2006. Preparation and characterization of genistein containing poly(ethylene glycol) microparticles. J. Appl. Polym. Sci. 101, 2070-2078.   DOI
18 Rimbach, G., De Pascual-Teresa, S., Ewins, B.A., Matsugo, S., Uchida, Y., Minihane, A.M., Turner, R., VafeiAdou, K., Weinberg, P.D., 2003. Antioxidant and free radical scavenging activity of isoflavone metabolites. Xenobiotica 33, 913-925.   DOI
19 Barnes, S., Grubbs, C., Setchell, K.D., Carlson, J., 1990. Soybeans inhibit mammary tumors in models of breast cancer. Prog. Clin. Biol. Res. 239-253.